Facing ethical challenges in rolling out antiretroviral treatment in resource-poor countries: Comment on "They call it 'patient selection' in Khayelitsha"

Cambridge Quarterly of Healthcare Ethics

Volumn 15, Issue 3, 2006, Pages 322-330

  Benatar, Solomon ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BENEFICENCE; DEVELOPING COUNTRY; ETHICAL THEORY; ETHICS; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; NOTE; PATIENT COMPLIANCE; PATIENT RIGHT; PATIENT SELECTION; PERSONAL AUTONOMY; PRESCRIPTION; PUBLIC HEALTH; SOCIAL JUSTICE; SOUTH AFRICA; STANDARD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; BENEFICENCE; DEVELOPING COUNTRIES; ETHICAL THEORY; HEALTH CARE RATIONING; HUMANS; INTERNATIONAL COOPERATION; MEDICAL MISSIONS, OFFICIAL; PATIENT COMPLIANCE; PATIENT RIGHTS; PATIENT SELECTION; PERSONAL AUTONOMY; PRESCRIPTIONS, DRUG; PUBLIC HEALTH; SOCIAL JUSTICE; SOUTH AFRICA;

EID: 33745562218     PISSN: 09631801     EISSN: 14692147     Source Type: Journal    
DOI: 10.1017/S0963180106060427     Document Type: Note

References (35)

1. Curran J, Debas H, Arya M, Kelley P, Knobler S, Pray L, eds. Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities. Washington, DC: National Academy Press; 2004. Available at: http:// www.nap.edu/catalog/11043.html;
2. Wassuna A. Human ethical issues arising in ARV scale-up in resource constrained settings. In: Scaling up Rx for the Global AIDS Pandemic. Washington, DC: National Academy Press; 2004.
3. In South Africa, 5.2 million people are HIV positive. In about 500,000 of these, destruction of the immune system by HIV has progressed to the point that ARV treatment is required (CD4 counts below 200). Currently, about 40,000 people are receiving ARV treatment in the public sector (about 8,000 through MSF) and another 45,000 in the private sector.
4. Benatar SR. Health care reform and the crisis of HIV and AIDS in South Africa. New England Journal of Medicine 2004;351:81-92.
5. Antiretroviral therapy in primary health care: Experience of the Khayelitsha program in South Africa. Case study. Geneva: World Health Organization; 2003.
6. Childress JF, Faden RR, Gaare RD, et al. Public health ethics: Mapping the terrain. Journal of Law, Medicine and Ethics 2002; 30:170-8;
7. Upshur REG. Principles for the justification of public health intervention. Canadian Journal of Public Health 2002;93:101-3;
8. Benatar SR. Public health and public health ethics. Acta Bioethica 2003;9(2):195-207;
9. Kass N. Public health ethics: From foundations to justice and global health. Journal of Law, Medicine and Ethics 2004;23(1):232-42.
10. Pellegrino E, Thomasma DC. For the Patient's Good: The Restoration of Beneficience in Health Care. New York: Oxford University Press; 1988.
11. The inability to weigh and balance values that cannot be measured against each other on any common scale - for example, additional years of normal life against years of disabled life.
12. Constitution of the Republic of South Africa 1996. Available at: http://www.polity.org.za/html/govdocs/constitution/ saconst.html?rebookmark=1 (accessed July 4, 2005).
13. Guidance on ethics & equitable access to HIV treatment & care. Geneva: World Health Organization; 2004;
14. Wilson P, Blower S. Designing equitable antiretroviral allocation strategies in resource-constrained countries. PloS Medicine 2005;2(2):0132-41;
15. Capron AM, Reis A. Designing an equitable strategy for allocating antiretroviral treatments. PloS Medicine 2005;2(2):0171-3.
16. Daniels N, Sabin J. Limits to health care: Fair procedures, democratic deliberation and the legitimacy problem for insurers. Philosophy & Public Affairs 1997;26(4):303-50.
17. See note 3, Benatar 2004.
18. See note 10, Daniels, Sabin 1997.
19. See note 1, Curran et al. 2004; Lamptey P, Wilson D. Scaling up AIDS treatment: What is the potential impact & what are the risks. PloS Medicine 2005;2(2):0102-4;
20. McCoy D, Chopra M, Loewenson R, Aitken J-M, Ngulube T, Muula A, Ray S, Kureyi T, et al. Expanding access to ARV therapy in sub-Saharan Africa: Avoiding the pitfall and dangers, capitalizing on the opportunities. America Journal of Public Health 2005;95(1):18-22;
21. Rosen S, Sanne I, Collier A, Simon JL. Hard choices: Rationing antiretroviral therapy for HIV/AIDS in Africa. Lancet 2005;365:354-6.
22. See note 3, Benatar 2004.
23. See note 9, Wilson, Blower 2005.
24. See note 1, Curran et al. 2004; note 3, Benatar 2004.
25. See note 5, Childress et al. 2002, Upshur 2002, Benatar 2003, Kass 2004; note 10 Daniels, Sabin 1997.
26. See note 5, Childress et al. 2002, Upshur 2002, Benatar 2003, Kass 2004.
27. See note 1, Curran et al. 2004.
28. Many missions. One voice: Justice and integrity in MSF operational choices. Holland: Médecins Sans Frontières; May 2003.
29. See note 1, Curran et al. 2004; note 3, Benatar 2004.
30. Dovlo D. Taking more than a fair share? The migration of health professionals from poor to rich countries. PLoS Medicine 2005;May 2(5)e109-0376-0379. Available at: http://medicine.plosjournals.org/perlserv/? request=get-document&doi=10.1371/journal.pmed.0020109.
31. Benatar SR. South Africa's transition in a globalising world: HIV/AIDS as a window and a mirror. International Affairs 2001; 77(2):347-75;
32. Benatar SR. Ethics and tropical diseases: A global perspective. In: Cook G, Zumla A, eds. Manson's Tropical Diseases, 21st ed. Edinburgh: Elsevier Science; 2003: 85-93.
33. Glover J. Humanity: A moral history of the 20th century. New Haven: Yale University Press; 2001.
34. See note 23, Benatar 2001; Benatar SR, Daar AS, Singer PA. Global health ethics: the rationale for mutual caring. International Affairs 2003;79:107-38.
35. Benatar SR. Moral imagination: the missing factor in global health. PLoS Med 2005;2(12):e400. Available at: http://medicine.plosjournals.org/perlserv/? request=get-document&doi=10%2E1371%2Fjournal%Epmed%2E0020400.